Access cutting-edge extranodal natural killer/t-cell lymphoma, nasal type treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Houston location
Preparing your pre-screening questions…
Access extranodal natural killer/t-cell lymphoma, nasal type specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related extranodal natural killer/t-cell lymphoma, nasal type treatment provided free
Check if you qualify for this extranodal natural killer/t-cell lymphoma, nasal type clinical trial in Houston, TX
No-Cost Study Care
Local to Houston
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study involved patients that have a cancer called diffuse large B cell lymphoma (DLBCL), NK and T cell lymphomas (NK/TL) or classical Hodgkin lymphoma (cHL) (hereafter these 3 diseases will be referred to as lymphoma). Patients lymphoma has come back or not gone away after treatment. Because there is no standard treatment for the patients cancer at this time or because the currently used treatments do not work fully in all cases, the patients are being asked to volunteer in this research study. In this study the investigators want to test a type of T cell made from a normal donor. The T cells the investigators will use are called Epstein Barr virus (EBV) specific T cells (EBVSTs) and are cells that the investigators have trained in the laboratory to recognize a EBV which is the virus that causes mono or kissing disease. Some patients with lymphoma have EBV in their cancer cells. Researchers have given T cell lines from normal donor EBVSTs to lymphoma patients who have EBV in their lymphoma cells and have seen responses in about half the patients. The cells have have been generated and are frozen in a bank. The cells are called "allogeneic" (meaning the donor is not related to the patient). CD30.CAR in EBV-specific T cells (called allogeneic CD30.CAR-EBVST) from the blood of healthy donors. The investigators are giving the cells to patients with lymphoma cells that express CD30. If the lymphoma cells also express EBV there may be some benefit from targeting both proteins. The purpose of this study is to find out the highest safe dose of allogeneic CD30.CAR-EBVST cells given following chemotherapy and used to treat lymphoma. The investigators will learn the side effects of CD30.CAR-EBVST cells in patients and see whether this therapy may help lymphoma patients
Sponsor: Baylor College of Medicine
Yes, this clinical trial (NCT04288726) has an active research site in Houston, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for extranodal natural killer/t-cell lymphoma, nasal type treatment options in Houston, TX, this clinical trial (NCT04288726) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced extranodal natural killer/t-cell lymphoma, nasal type specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all extranodal natural killer/t-cell lymphoma, nasal type clinical trials near you to find additional studies recruiting in your area.
See all lymphoma clinical trials recruiting in Houston — not just this study.
Browse Lymphoma Trials in Houston →